IP/Trade TRIPS Waiver Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, PET scan coverage and reimbursement, and dementia care
Appropriations on Alzheimers screening and diagnosis
H.R.19, Lower Costs, More Cures Act of 2021
Discussions regarding FDA approval of Aduhelm Discussions regarding Medicaid 340B drug discount program
Reducing Out-of-Pocket Costs for Biosimilars in Medicare Part B S.Con.Res.14, FY 2022 Congressional Budget H.R.3/S.2543, Elijah E. Cummings Lower Drug Costs Now Act, discussions regarding support to increase Part B biosimilar payments from ASP +6% to ASP +8% of the reference product
TRD - Trade (domestic/foreign) HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations PHA - Pharmacy
136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BIOGEN
601 PENNSYLVANIA AVENUE, NW #720, WASHINGTON, DC, 20004, US
JONATHAN CAUSEY JONATHAN CAUSEY JOHN RAYMOND GIBSON CAROLINE TUCKER SUSAN KORNETSKY AMY DEMSKE AMY ABADIR AMY DEMSKE AMY ABADIR CAROLINE TUCKER TYLER HANSON (Office of Rep. McNerney 6/2015 - 2/2017) JONATHAN CAUSEY JONATHAN CAUSEY
Office of Rep. McNerney 6/2015 - 2/2017